HealthAssure
HealthAssureGood Life
LOINCActiveBoth

LOINC Code 76544-6: Breast cancer 10-year risk of distant recurrence score Calculated by Prosigna [Score]

76544-6 is a LOINC code used to identify Breast cancer 10-year risk of distant recurrence score Calculated by Prosigna [Score] in laboratory and clinical observation data. You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges. LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Breast cancer 10Y risk of distant recurrence score. It is commonly used with the system or sample type ^Patient.

Reviewed by HealthAssure Clinical TeamUpdated 21 May 2026

What is this code?

LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Breast cancer 10Y risk of distant recurrence score. It is commonly used with the system or sample type ^Patient.

When is it used?

  • Used in lab systems, EHRs, and clinical data exchange.
  • May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
  • Status: ACTIVE
  • Order vs observation: Both
  • Method: Calculated.Prosigna

What it does not mean

  • The code identifies the observation or test, not the actual result.

Key facts

Breast cancer 10-year risk of distant recurrence score Calculated by Prosigna
Breast cancer 10Y risk of distant recurrence score
The 10-year breast cancer distant recurrence risk score (also referred to as ROR Score or Risk of Recurrence Score) is a numerical score on a scale of 0 -100 that is calculated using a statistical model that includes1) the results from a 50-gene expression assay performed on formalin fixed paraffin embedded breast tumor tissue previously diagnosed as invasive carcinoma; 2) proliferation score; and 3) gross tumor size. The calculated score and information about lymph node status are used together to classify the patient into a risk category for distant breast cancer recurrence at 10 years. This term was created for the Prosigna™ Breast Cancer Prognostic Gene Signature assay, which is intended for use in postmenopausal women with node-negative (Stage I or II) or node-positive (Stage II), hormone receptor-positive (HR+) breast cancer who have undergone surgery and are to be treated with adjuvant endocrine therapy alone.
breast cancer; Brst ca 10Y risk dist recur score; Calc; Calc.Prosigna; Calculation; Molecular pathology; MOLPATH; PAM50; Point in time; Prosigna; Psoriasis Care Satisfaction questionnaire; QNT; Quan; Quant; Quantitative; Random; Risk of recurrence score; ROR; Scale; Scre

Where you may see this code

You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.

Common synonyms

Breast cancer 10-year risk of distant recurrence score Calculated by Prosigna [Score]Breast cancer 10-year risk of distant recurrence score Calculated by ProsignaBrst ca 10Y dist recur score ProsignaBreast cancer 10Y risk of distant recurrence scoreMOLPATHBreast cancer 10-year risk of distant recurrence scoreScore

Frequently asked questions

Code details

Code76544-6
SystemLOINC
Display nameBreast cancer 10-year risk of distant recurrence score Calculated by Prosigna [Score]
DescriptionBreast cancer 10Y risk of distant recurrence score
Short nameBrst ca 10Y dist recur score Prosigna
ComponentBreast cancer 10Y risk of distant recurrence score
PropertyScore
TimingPt
System (specimen)^Patient
ScaleQn
MethodCalculated.Prosigna
ClassMOLPATH
Example unitsscore
StatusACTIVE
Order/ObservationBoth

Flags

BillableNo
Valid clinical useNo

Source

SourceLOINC
Version2.82
Releasemain
First released2.52
Last changed2.73

Consumer names

Breast cancer 10-year risk of distant recurrence score

Part names

Breast cancer 10Y risk of distant recurrence scoreScorePt^PatientQnCalculated.ProsignaBreast cancer 10-year risk of distant recurrence scorePoint in time (spot)Calculated by Prosigna

About this content

This page is prepared by HealthAssure's clinical team using official coding standards from LOINC. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.